Abstract
To determine how L-dopa stimulates GH secretion, we investigated its interaction with GHRH in vivo. Six normal men were studied on 4 occasions: 1) L-dopa-TRH: 500 mg L-dopa orally followed by 200 µg TRH 60 min later; 2) L-dopa-GHRH-TRH: 100 µg GHRH 1-44 iv 30 min after L-dopa followed by 200 µg TRH iv; 3) GHRH-TRH: 100 µg GHRH iv at 0 min, 30 min later 200 µg TRH iv; 4) TRH test: 200 µg TRH iv as a bolus. After L-dopa-TRH GH-levels increased significantly from 0.6 µg/l to 25.8 ± 9.6 (SE) µg/l at 60 min. Only a slight TSH and no PRL increase was observed after L-dopa-TRH. After L-dopa-GHRH-TRH the GH-increase was significantly higher (45.7 ± 11.1 µg/l) compared to L-dopa-TRH alone. GHRH-TRH increased GH-levels to 52.5 ± 12.1 µg/l, which was not significantly different from the GH-levels obtained when L-dopa-GHRH-TRH were given. TRH increased serum TSH and PRL to 6.3 ± 0.7 µU/ml and 715 ± 136 µU/ml, respectively, which was significantly higher compared to the TSH responses after L-dopa-TRH. The PRL and TSH increase after TRH only was also higher (TSH-max: 5.7 ± 0.5 µU/ml; PRL-max: 899 ± 154 µU/ml) compared to the TSH and PRL responses after L-dopa-TRH. Our results show that the combination of L-dopa with GHRH leads to the same GH response as GHRH only. However, both responses are significantly higher than the one after L-dopa alone. This observation indicates that the stimulatory effect of L-dopa on GH secretion is mediated by endogenous GHRH. The inhibition of the TSH and PRL response to TRH after L-dopa administration, however, is due to the direct action of the L-dopa metabolite dopamine on the anterior pituitary.
Similar content being viewed by others
References
Boyd A.E., Lebovitz H.E., Pfeiffer J.B. Stimulation of human-growth-hormone secretion by L-dopa. N. Engl. J. Med. 253: 1425, 1970.
Dieguez C., Valcavi R., Page M. D., Zini M., Casoli P., Edwards C.A., Portioli I., Scanion M.F. L-dopa releases GH via a GRF dependent mechanism in normal human subjects, whereas arginine, clonidine and adrenalin plus propanolol do not. 3rd Meeting of the European Neuroendocrine Association, London, 1987, Abstract 126.
Delitala G., Palermo M., Ross R., Coy D., Besser M., Grossman A. Dopaminergic and cholinergic influences on the growth hormone response to growth hormone-releasing hormone in man. Neuroendocrinology 45: 243, 1987.
Vance M.L., Kaiser D.L., Frohman L. A., Rivier J., Vale W. W., Thorner M. O. Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man. J. Clin. Endocrinol. Metab. 64: 1136, 1987.
Penny E.S., Penman E., Price J., Rees L.H., Sopwith A.M., Wass J.A.H., Lytras N., Besser G.M. Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly. Br. Med. J. 289: 453, 1984.
Sopwith A.M., Penny E.S., Besser G.M., Rees L.H. Stimulation by food of peripheral plasma immunoreactive growth hormone releasing factor. Clin. Endocrinol. (Oxf.) 22: 337, 1985.
Von Werder K. Wachstumshormone und Prolaktinsekretion beim Menschen. Urban und Schwarzenberg, Munich-Berlin-Wien, 1975.
Wass J.A.H. Growth hormone neuroregulation and the clinical relevance of somatostatin. Clin. Endocrinol. Metabol. 12: 695, 1983.
Page M.D., Dieguez C., Valcavi R., Edwards C., Hall R., Scanion M.F. Growth hormone (GH) responses to arginrne and L-dopa alone and after GHRH pretreatment. Clin. Endocrinol. (Oxf.) 28: 551, 1988.
Marcovitz S., Goodyear G.C., Guyda H., Gardiner R.J., Hardy J. Comparative study of human fetal, normal adult and somatotropic adenoma pituitary function in tissue culture. J. Clin. Endocrinol. Metab. 54: 6, 1982.
Delitala G., Tomasi P., Virdis R. Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications. J. Endocrinol. Invest. 11: 441, 1988.
Dieguez C., Page M.D., Scanion, M.F. Growth hormone neuroregulation and its alterations in disease states. Clin. Endocrinol. (Oxf.) 28: 109, 1988.
Losa M., Stalla G.K., Müller O.A., von Werder K. Human pancreatic growth hormone releasing factor (hpGRF): dose reponse of GRF-and GH-levels. Klin. Wochenschr. 61: 1249, 1983.
Siler T.M., Yen S.S.C., Vale W., Guillemin R. Inhibition by somatostatin of the release of TSH induced in man by thyrotropin-releasing factor. J. Clin. Endocrinol. Metab. 38: 742, 1974.
Alba-Roth J., Müller O.A., Schopohl J., von Werder K. Arginine stimulates growth hormone secretion by suppression of endogenous somatostatin secretion. J. Clin. Endocrinol. Metab. 67: 1186, 1988.
Chihara K., Kashio Y., Kita T., Okimura Y., Kaji H., Abe H., Fujita T. L-dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans. J. Clin. Endocrinol. Metab. 62: 466, 1986.
Masuda A., Shibasaki T., Imaki T., Demura H., Shizume K. The manner of GHRH involvement in GH stimulation test in man. 1st International Congress of Neuroendocrinology, San Francisco, USA, Abstract 186. 1986.
Tapanainen P., Knip M., Lautala P., Leppäluoto J. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men. J. Clin. Endocrinol. Metab. 67: 845, 1988.
Donnadieu M., Evain-Brion D., Tonon M.C., Vaudry H. Job J.C. Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children. J. Clin. Endocrinol. Metab. 60: 1132, 1985.
Giusti M., Mazzochi P., Sessarego P., Mignone D., Lomeo A., Monachesi M., Giordano G. Effects of GRF (1–40) and Domperidone on GH secretion in normal men. Clin Endocrinol. (Oxf.) 21: 339, 1984.
Looij J.R., Nieuwenhuijzen Kruseman A.C., Mudde A.H., Frölich M., Piaditis G.P., Hodgkinson S.C., McLean C., Grossman A., Coy D.H., Rees L.H., Lowry P.J., Besser G.M. The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones. Clin Endocrinol. (Oxf.) 24: 149, 1986.
Schopohl J., Losa M., König A., Müller O.A., Stalla G.K., von Werder K. Combined pituitary function-test with four hypothalamic releasing hormones. Klin. Wochenschr. 64: 314, 1986.
Author information
Authors and Affiliations
Additional information
Supported by the Deutsche Forschungsgemeinschaft (We 439/5-2; Mu 585/3-3). Dr. J. Alba-Roth was a fellow of the DAAD.
Rights and permissions
About this article
Cite this article
Alba-Roth, J., von Creytz, C., Mehltretter, G. et al. Interaction of L-dopa and GHRH on GH secretion in normal men. J Endocrinol Invest 12, 783–787 (1989). https://doi.org/10.1007/BF03350059
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350059